Acumen Pharmaceuticals (ABOS) Non-Current Assets (2021 - 2026)
Acumen Pharmaceuticals (ABOS) reported Non-Current Assets of $494,000 for Q2 2026, down 97.9% from $23.49 million a year earlier and down 7.7% from the prior quarter.
Acumen Pharmaceuticals (ABOS) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Acumen Pharmaceuticals posted Non-Current Assets of $581,000, down 99.0% from FY2024.
- Non-Current Assets has a four-year compound annual growth rate of -63.2% (FY2021 to FY2025).
- By year, Non-Current Assets came in at $60.69 million in FY2024 (-4.4%), $63.51 million in FY2023 (+290.6%), $16.26 million in FY2022 (-48.7%) and $31.67 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q2 2021.
- Year over year, Non-Current Assets has now declined in each of the last four quarters, with an average decline of 47.4% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q2 2022 (growth of 769.9%); the low point was Q4 2025 (a decline of 99.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $535,000 (Q1 2026), $581,000 (Q4 2025) and $10.07 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.99 Bn | 1,104.58 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 616.90 Bn | 535.42 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.56 Bn | 474.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.13 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.48 Bn | 191.88 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.56 Bn | 164.76 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Acumen Pharmaceuticals | 148.11 Mn | -333.96 Mn | - | 494,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 494,000.00 |
| Mar 31, 2026 | 535,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | 10.07 Mn |
| Jun 30, 2025 | 23.49 Mn |
| Mar 31, 2025 | 49.53 Mn |
| Dec 31, 2024 | 60.69 Mn |
| Sep 30, 2024 | 59.34 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 45.14 Mn |
| Dec 31, 2023 | 63.51 Mn |
| Sep 30, 2023 | 67.77 Mn |
| Jun 30, 2023 | 27.87 Mn |
| Mar 31, 2023 | 43.83 Mn |
| Dec 31, 2022 | 16.26 Mn |
| Sep 30, 2022 | 704,000.00 |
| Jun 30, 2022 | 20.63 Mn |
| Mar 31, 2022 | 27.99 Mn |
| Dec 31, 2021 | 31.67 Mn |
| Sep 30, 2021 | 29.94 Mn |
Acumen Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();